Company Filing History:
Years Active: 2023
Title: Maureen Caligiuri: Innovator in Cancer Treatment
Introduction
Maureen Caligiuri is a prominent inventor based in Watertown, MA (US). She has made significant contributions to the field of cancer treatment, particularly in developing methods for treating androgen receptor-driven cancers. Her innovative work has the potential to impact the lives of many patients suffering from these conditions.
Latest Patents
Maureen Caligiuri holds a patent for "Bromodomain inhibitors for androgen receptor-driven cancers." This patent discloses methods for treating certain androgen receptor-positive forms of cancer using inhibitors of the CREB binding protein bromodomain. The patent specifically addresses treatments for breast cancer, including triple-negative forms, hormone receptor-positive forms, and HER2-positive forms. Additionally, it covers methods for treating prostate cancer, including metastatic castration-resistant prostate cancer. The patent includes the administration of a specific compound, (1R,3R)-3-[(7S)-2-[(R)-(5-fluoro-2-methoxyphenyl)(hydroxy)methyl]-6-(methoxycarbonyl)-7-methyl-3H,6H,7H,8H,9H-imidazo[4,5-f]quinolin-3-yl]cyclohexane-1-carboxylic acid, or a pharmaceutically acceptable salt thereof.
Career Highlights
Maureen Caligiuri is currently associated with Forma Therapeutics, Inc., where she continues her research and development efforts. Her work focuses on innovative solutions for cancer treatment, showcasing her dedication to advancing medical science.
Collaborations
Some of her notable coworkers include Sylvie Guichard and Anna M Ericsson. Their collaborative efforts contribute to the ongoing research and development in the field of cancer therapies.
Conclusion
Maureen Caligiuri's contributions to cancer treatment through her innovative patents and work at Forma Therapeutics, Inc. highlight her role as a leading inventor in the medical field. Her research has the potential to change the landscape of cancer therapies and improve patient outcomes.